SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001493152-16-014392
Filing Date
2016-11-01
Accepted
2016-11-01 09:01:08
Documents
9
Period of Report
2016-11-01
Filing Date Changed
2016-11-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 30471
2 ex99-1.htm EX-99.1 8973
3 image_001.jpg GRAPHIC 159261
4 image_002.jpg GRAPHIC 198419
5 image_003.jpg GRAPHIC 139199
6 image_004.jpg GRAPHIC 173482
7 image_005.jpg GRAPHIC 168351
8 image_006.jpg GRAPHIC 139229
9 image_007.jpg GRAPHIC 91183
  Complete submission text file 0001493152-16-014392.txt   1513715
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 161963389
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1